A daily pill developed by the US pharmaceutical company Lilly may become a convenient alternative to injectable drugs like ...

"GLP-1 medications are currently the most effective weight loss adjunct available if the patient does not meet the criteria ...

This week in Ozempic news: No more compounded GLP-1s, weight-loss pills are coming, and WeightWatchers is filing for ...

A recent medical trial could help deliver the first daily weight loss pill capable of cutting down obesity as effectively as ...

Pharmaceutical giant Eli Lilly (LLY) surged 14% last week to $840 per share following positive Phase 3 trial results for its ...

Based, GLP-1 Inspired Weight Loss Supplement as a Natural Alternative to Mounjaro in 2025Aurora, Colorado, April 23, ...

The pecking order of the obesity drug market is shifting. Eli Lilly , the $815 billion maker of blockbuster weight-loss drugs ...

Drug manufacturer Eli Lilly has announced their new daily pill may be as effective in lowering blood sugar and aiding weight loss in people with Type 2 diabetes as Ozempic and Mounjaro. Emory's Dr.

Key takeaways Eli Lilly has filed lawsuits against four telehealth companies—Mochi Health, Fella Health, Willow Health, and ...

The future of telehealth is trust, combined with patient education. As the market matures, all parties — providers, ...